<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34773059</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines.</ArticleTitle><Pagination><StartPage>22154</StartPage><MedlinePgn>22154</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22154</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-01689-2</ELocationID><Abstract><AbstractText>CRISPR prime-editors are emergent tools for genome editing and offer a versatile alternative approach to HDR-based genome engineering or DNA base-editors. However, sufficient prime-editor expression levels and availability of optimized transfection protocols may affect editing efficiencies, especially in hard-to-transfect cells like hiPSC. Here, we show that piggyBac prime-editing (PB-PE) allows for sustained expression of prime-editors. We demonstrate proof-of-concept for PB-PE in a newly designed lentiviral traffic light reporter, which allows for estimation of gene correction and defective editing resulting in indels, based on expression of two different fluorophores. PB-PE can prime-edit more than 50% of hiPSC cells after antibiotic selection. We also show that improper design of pegRNA cannot simply be overcome by extended expression, but PB-PE allows for estimation of effectiveness of selected pegRNAs after few days of cultivation time. Finally, we implemented PB-PE for efficient editing of an amyotrophic lateral sclerosis-associated mutation in the SOD1-gene of patient-derived hiPSC. Progress of genome editing can be monitored by Sanger-sequencing, whereas PB-PE vectors can be removed after editing and excised cells can be enriched by fialuridine selection. Together, we present an efficient prime-editing toolbox, which can be robustly used in a variety of cell lines even when non-optimized transfection-protocols are applied.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eggenschwiler</LastName><ForeName>Reto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3588-7847</Identifier><AffiliationInfo><Affiliation>Research Group Translational Hepatology and Stem Cell Biology, Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625, Hannover, Germany. eggenschwiler.reto@mh-hannover.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>REBIRTH-Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625, Hannover, Germany. eggenschwiler.reto@mh-hannover.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gschwendtberger</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Systems Neuroscience, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felski</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research Group Translational Hepatology and Stem Cell Biology, Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>REBIRTH-Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahn</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0226-2464</Identifier><AffiliationInfo><Affiliation>Research Group Translational Hepatology and Stem Cell Biology, Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>REBIRTH-Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langer</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Research Group Translational Hepatology and Stem Cell Biology, Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>REBIRTH-Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterneckert</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Regenerative Therapies Dresden (CRTD), Technische Universit&#xe4;t Dresden, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology and Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, 18147, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xfc;hmann</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9446-2411</Identifier><AffiliationInfo><Affiliation>Institute of Human Genetics, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinemann</LastName><ForeName>Doris</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8797-0816</Identifier><AffiliationInfo><Affiliation>Institute of Human Genetics, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haase</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>REBIRTH-Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), German Center for Lung Research (DZL), 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0003-1058-4540</Identifier><AffiliationInfo><Affiliation>REBIRTH-Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), German Center for Lung Research (DZL), 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petri</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Systems Neuroscience, Hannover Medical School, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantz</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1382-9577</Identifier><AffiliationInfo><Affiliation>Research Group Translational Hepatology and Stem Cell Biology, Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625, Hannover, Germany. cantz.tobias@mh-hannover.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>REBIRTH-Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625, Hannover, Germany. cantz.tobias@mh-hannover.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max Planck Institute for Molecular Biomedicine, Cell and Developmental Biology, 48149, Munster, Germany. cantz.tobias@mh-hannover.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="Y">CRISPR-Cas Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072669" MajorTopicYN="N">Gene Editing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34773059</ArticleId><ArticleId IdType="pmc">PMC8589839</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-01689-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-01689-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gaudelli NM, et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature. 2017;551:464&#x2013;471. doi: 10.1038/nature24644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24644</ArticleId><ArticleId IdType="pmc">PMC5726555</ArticleId><ArticleId IdType="pubmed">29160308</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzalone AV, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576:149&#x2013;157. doi: 10.1038/s41586-019-1711-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1711-4</ArticleId><ArticleId IdType="pmc">PMC6907074</ArticleId><ArticleId IdType="pubmed">31634902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, et al. Predicting the efficiency of prime editing guide RNAs in human cells. Nat. Biotechnol. 2021;39:198&#x2013;206. doi: 10.1038/s41587-020-0677-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0677-y</ArticleId><ArticleId IdType="pubmed">32958957</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabe M, et al. The epidemiology of CuZn-SOD mutations in Germany: A study of 217 families. J. Neurol. 2010;257:1298&#x2013;1302. doi: 10.1007/s00415-010-5512-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5512-9</ArticleId><ArticleId IdType="pubmed">20309572</ArticleId></ArticleIdList></Reference><Reference><Citation>Certo MT, et al. Tracking genome engineering outcome at individual DNA breakpoints. Nat. Methods. 2011;8:671&#x2013;676. doi: 10.1038/nmeth.1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1648</ArticleId><ArticleId IdType="pmc">PMC3415300</ArticleId><ArticleId IdType="pubmed">21743461</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu VT, et al. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat. Biotechnol. 2015;33:543&#x2013;548. doi: 10.1038/nbt.3198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3198</ArticleId><ArticleId IdType="pubmed">25803306</ArticleId></ArticleIdList></Reference><Reference><Citation>Biasco L, Rothe M, Buning H, Schambach A. Analyzing the genotoxicity of retroviral vectors in hematopoietic cell gene therapy. Mol. Ther. Methods Clin. Dev. 2018;8:21&#x2013;30. doi: 10.1016/j.omtm.2017.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2017.10.002</ArticleId><ArticleId IdType="pmc">PMC5684499</ArticleId><ArticleId IdType="pubmed">29159200</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggenschwiler R, et al. Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy. Stem Cells Transl. Med. 2013;2:641&#x2013;654. doi: 10.5966/sctm.2013-0017.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2013-0017</ArticleId><ArticleId IdType="pmc">PMC3754465</ArticleId><ArticleId IdType="pubmed">23926210</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf, R., Li, X., Chu, V. T. &amp; Rajewsky, K. sgRNA sequence motifs blocking efficient CRISPR/Cas9-mediated gene editing. Cell Rep.26, 1098&#x2013;1103 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6352712</ArticleId><ArticleId IdType="pubmed">30699341</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen MW, et al. Predictable and precise template-free CRISPR editing of pathogenic variants. Nature. 2018;563:646&#x2013;651. doi: 10.1038/s41586-018-0686-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0686-x</ArticleId><ArticleId IdType="pmc">PMC6517069</ArticleId><ArticleId IdType="pubmed">30405244</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase A, Gohring G, Martin U. Generation of non-transgenic iPS cells from human cord blood CD34(+) cells under animal component-free conditions. Stem Cell Res. 2017;21:71&#x2013;73. doi: 10.1016/j.scr.2017.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2017.03.022</ArticleId><ArticleId IdType="pubmed">28677540</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggenschwiler R, et al. Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase. Sci. Rep. 2016;6:38198. doi: 10.1038/srep38198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep38198</ArticleId><ArticleId IdType="pmc">PMC5133597</ArticleId><ArticleId IdType="pubmed">27910942</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusa K, Zhou L, Li MA, Bradley A, Craig NL. A hyperactive piggyBac transposase for mammalian applications. Proc. Natl. Acad. Sci. USA. 2011;108:1531&#x2013;1536. doi: 10.1073/pnas.1008322108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008322108</ArticleId><ArticleId IdType="pmc">PMC3029773</ArticleId><ArticleId IdType="pubmed">21205896</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano S, Nishimasu H, Ishitani R, Nureki O. Structural basis for the altered PAM specificities of engineered CRISPR-Cas9. Mol. Cell. 2016;61:886&#x2013;894. doi: 10.1016/j.molcel.2016.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.02.018</ArticleId><ArticleId IdType="pubmed">26990991</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu JH, et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature. 2018;556:57&#x2013;63. doi: 10.1038/nature26155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature26155</ArticleId><ArticleId IdType="pmc">PMC5951633</ArticleId><ArticleId IdType="pubmed">29512652</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton RT, Christie KA, Whittaker MN, Kleinstiver BP. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science. 2020;368:290&#x2013;296. doi: 10.1126/science.aba8853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aba8853</ArticleId><ArticleId IdType="pmc">PMC7297043</ArticleId><ArticleId IdType="pubmed">32217751</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. piggyBac transposase tools for genome engineering. Proc. Natl. Acad. Sci. USA. 2013;110:E2279&#x2013;2287. doi: 10.1073/pnas.1305987110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1305987110</ArticleId><ArticleId IdType="pmc">PMC3690869</ArticleId><ArticleId IdType="pubmed">23723351</ArticleId></ArticleIdList></Reference><Reference><Citation>Bothmer A, et al. Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus. Nat. Commun. 2017;8:13905. doi: 10.1038/ncomms13905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13905</ArticleId><ArticleId IdType="pmc">PMC5227551</ArticleId><ArticleId IdType="pubmed">28067217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinstiver BP, et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature. 2015;523:481&#x2013;485. doi: 10.1038/nature14592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14592</ArticleId><ArticleId IdType="pmc">PMC4540238</ArticleId><ArticleId IdType="pubmed">26098369</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee P, et al. A Cas9 with PAM recognition for adenine dinucleotides. Nat. Commun. 2020;11:2474. doi: 10.1038/s41467-020-16117-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16117-8</ArticleId><ArticleId IdType="pmc">PMC7235249</ArticleId><ArticleId IdType="pubmed">32424114</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkman EK, Chen T, Amendola M, van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014;42:e168. doi: 10.1093/nar/gku936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku936</ArticleId><ArticleId IdType="pmc">PMC4267669</ArticleId><ArticleId IdType="pubmed">25300484</ArticleId></ArticleIdList></Reference><Reference><Citation>Naujock M, et al. 4-Aminopyridine induced activity rescues hypoexcitable motor neurons from amyotrophic lateral sclerosis patient-derived induced pluripotent stem cells. Stem Cells. 2016;34:1563&#x2013;1575. doi: 10.1002/stem.2354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2354</ArticleId><ArticleId IdType="pubmed">26946488</ArticleId></ArticleIdList></Reference><Reference><Citation>Maetzig T, Galla M, Brugman MH, Loew R, Baum C, Schambach A. Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors. Gene Ther. 2010;17:400&#x2013;411. doi: 10.1038/gt.2009.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gt.2009.129</ArticleId><ArticleId IdType="pubmed">19847204</ArticleId></ArticleIdList></Reference><Reference><Citation>Canver MC, et al. Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci. Nat. Genet. 2017;49:625&#x2013;634. doi: 10.1038/ng.3793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3793</ArticleId><ArticleId IdType="pmc">PMC5374001</ArticleId><ArticleId IdType="pubmed">28218758</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaue-Sawano A, et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell. 2008;132:487&#x2013;498. doi: 10.1016/j.cell.2007.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.12.033</ArticleId><ArticleId IdType="pubmed">18267078</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>